New EU Limits On Pyrrolizidine Alkaloids In Dietary Supplements Take Effect
Executive Summary
Following a transitional period of 18 months, maximum levels for pyrrolizidine alkaloids in dietary supplements come into force in the EU from 1 July 2022 for new products placed on the market. Pyrrolizidine alkaloids have been under scrutiny in the EU for over a decade as their consumption has been linked to a number of health issues, including liver damage.
You may also be interested in...
EU CBD Novel Food Applications On Hold As EFSA Considers Health Risks
All European Union CBD novel food applications have been paused by EFSA after its Panel on Nutrition, Novel Foods and Food Allergens raised concerns about the ingredient's safety, pointing in a wide-ranging scientific literature review to a number of data gaps related to bioavailability, liver damage, gastrointestinal issues and possible negative impacts on pregnancy and reproductive health.
EFSA Considers Vitamin D Max Levels As Part Of VMS Evidence Review
Vitamin D is one of eight micronutrients being reviewed by the European Food Safety Authority in terms of tolerable upper intake levels (ULs).
Nestlé Partner Valbiotis Hails Trial Results For Prediabetes Supplement
Valbiotis and Nestlé Health Science plan to launch in 2024 a dietary supplement targeted at sufferers of prediabetes and type-2 diabetes following positive results from a recent study which showed the product's efficacy on key markers of glucose metabolism.